[6] World Health Organization. Preventing and managing the Global
Epidemic. Geneva: World Health Organization; 1998.
[7] Lean MEJ. Morrison waist circumference as a measure for indicating
need for weight management. BMJ 1995;311.
[8] Rifal N, Bachorik PS, Albers JJ. Lipids, lipoproteins and apolipoproteins.
In: Burtis CA, Ashwood ER, editors. Tietz text book of clinical chemistry.
3rd ed. Philadelphia: W.B Saunders Company; 1999. p. 809-61.
[9] Allain CC, et al. Enzymatic determination. Clin Chem 1974;20:470.
[10] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the
concentration of low density lipoprotein cholesterol in plasma, with-
out use of the preparative ultracentrifugation. Clin Chem 1997;18:
499-502.
[11] Josef S, David WR, Nina I, et al. Molecular cloning: rapid isolation of
mammalian DNA. New York: Cold Spring Harbour Laboratory Press;
2002. p. 628-30.
[12] Emery AE. Methodology in medical genetics- an introduction to
statistical methods. Edinburgh: Longman; 1986.
[13] Karine C, Chad G, Jorg H, et al. Indication for linkage of human
OB gene region with extreme obesity. Cell 1996;45:687-90.
[14] Clement K, Garner C, Hager J, et al. Indication for linkage of the
human OB gene region with extreme obesity. Diabetes 1996;45:
687-90.
[15] Shintani M, Ikegami H, Yamato E, et al. A novel microsatellite
polymorphism in the human OB gene: a highly polymorphic marker
for linkage analysis. Diabetologia; 1996;39:1398-401.
[16] Danielle RR, Yuan D, Weizhen X, et al. Extreme obesity may be linked
to markers flanking the human OB gene. Diabetes 1996;45:691-4.
[17] Shintani M, Ikegami H, Tomomi F, et al. Leptin gene polmorphism Is
associated with Hypertension Independent of obesity. 2002;87:2909-
2912.
doi:10.1016/j.jcrc.2008.06.007
Polymorphism of glutathione S-transferases as genetic risk
factors for the development of complications in type 2
diabetes mellitus
B
Aysheh M. Hossaini, Israa M. Zamrroni, Reem A. Kashem, Zoiya F.M. Khan
Second Year Medical Students. Dubai Medical College for Girls. Dubai, UAE
Keywords:
GSTM1;
GSTT1;
DM
Abstract
Background: Diabetes is characterized by chronic hyperglycemia that produces dysregulation of cellular
metabolism and result in excess free radical production and oxidative stress. Glutathione S-transferases
(GSTs) are a family of multifunctional enzymes that work as antioxidants. Therefore, diminished
expression of GSTs may result in a reduced body defense against oxidative stress, followed by
development of diabetic complications.
Objectives: To investigate the possible association between GSTM1 and GSTT1 polymorphism and the
occurrence of complications in type 2 DM and to study the other risk factors for complications in DM.
Methods: Twenty noncomplicated type 2 diabetic patients and 40 complicated type 2 diabetic patients
were enrolled in the study. The GSTM1 and GSTT1 genotypes were identified by polymerase chain
reaction of peripheral blood DNA samples. Analysis of data was done by using SPSS (SPSS, Chicago, Ill).
Results: The frequencies of null GSTM1 and GSTT1 genotypes were 55% (11/20) and 40% (8/20),
respectively, in noncomplicated DM group. The frequencies of null GSTM1 and GSTT1 genotype in
complicated DM group were 57.5% (23/40) and 60% (24/40), respectively. The null GSTT1 genotype was
more prevalent in the group of complicated DM with odds ratio (odds ratio, 2.3; 95% confidence interval,
0.75-6.7) when compared with noncomplicated DM.
Conclusion: Our data provide evidence that diabetics with null GSTT1 genotypes are substantially at
higher risk for developing complications.
© 2008 Published by Elsevier Inc.
☆
Source of research support: Dubai Medical College for Girls.
444 K. Shukri et al.